An inhibitor of protein aggregation inhibits a-synuclein oligomer formation and PrPSc prion propagation at 10 UM inhibits brain accumulation of PrPSc in and increases survival of prion-infected mice at 1 mg/animal reduces brain tau deposition and rescues glucose metabolic decline in a human tau transgenic mouse model of Alzheimers disease dietary administration reduces the formation of a-synuclein oligomers and glial cytoplasmic inclusions microglial activation and dopaminergic neuron degradation as well as preserves motor function in a mouse model of MSA at 0 6 and 2 g/kg chow